title: Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: pro.
authors.affiliation: Department of Neurology, University of Heidelberg, Germany. Peter-Schellinger@med.uni-heidelberg.de
authors.forename: Peter D
authors.initials: PD
authors.lastname: Schellinger
authors.forename: Jochen B
authors.initials: JB
authors.lastname: Fiebach
mesh_terms: D038524:Diffusion Magnetic Resonance Imaging; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D018810:Magnetic Resonance Angiography; D018579:Patient Selection; D011994:Recombinant Proteins / Q000627:therapeutic use; D020521:Stroke / Q000175:diagnosis* / Q000188:drug therapy*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000235:genetics / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
chemical_list: D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator